Eva Compérat, MD, PhD, Medical University of Vienna, Vienna, Austria, discusses diagnosing prostate cancer, from conventional to molecular diagnostics and how molecular subtypes can improve it. This interview took place at the EAU congress in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.